Lorena Lerner

Chief Scientific Officer @Keros Therapeutics

Lexington, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2025 — Present

Chief Scientific Officer @Keros Therapeutics

View department →

Lexington, MA, US

I am a Chief Scientific Officer with over two decades of experience in the biopharmaceutical industry, dedicated to translating innovative science into transformative therapies. My career is defined by a deep commitment to developing novel treatments for patients with significant unmet medical needs, particularly in rare diseases and oncology.At Keros Therapeutics, I lead our research and development strategy, guiding a diverse therapeutics pipeline from target identification to clinical development. My passion lies in building and empowering high-performing scientific teams, fostering a culture of rigorous scientific inquiry, and driving strategic initiatives that align with our mission to deliver life-changing medicines.

EDUCATION

1993 — 1994

University of Buenos Aires

MS, Molecular Biology

1995 — 2000

University of Buenos Aires

PhD, Biochemistry

SKILLS

Vector CloningAntibodiesLife SciencesAssay DevelopmentCellIn VitroMolecular BiologyIn VivoCancer ResearchHigh Throughput ScreeningChromatographyCell BiologySignal TransductionDrug DevelopmentDrug DiscoveryCancerTranslational ResearchPharmacologyClinical DevelopmentTranslational MedicineNanotechnologyMolecular CloningVector DesignBiochemistryTumor ImmunologyNanoparticlesBiomarkersBiotechnology

ABOUT LORENA LERNER

Innovative, creative and experienced executive leader with a track record of success in drug discovery, from target identification to clinical development. Demonstrated success in translating drug candidates from preclinical to clinical development, including IND submission and interactions with regulatory authorities. Diverse therapeutic area research experience, including oncology/immuno-oncology, pharmacology, nanotechnology, and hematological, musculoskeletal, and metabolic disorders, spanning gene therapy, oncolytic viruses, LNP/RNA, biologics, including monoclonal and bispecific antibodies. Significant strategic and operational experience on senior leadership teams and governance bodies responsible for research strategy and prioritization, budgets, intellectual portfolio, and competitive landscape analysis. Broad experience in cooperating transversally in matrix environments, highly accomplished in forming effective relationships with key stakeholders, including CMC and Clinical teams. Well-developed presentation skills, strategic communication to BOD, SAB, CAB, executive leadership, and external audiences. Spearheaded and led numerous external collaborations with academic groups, CROs and Pharma. Demonstrated success in hiring and building high-performing teams, deep understanding, and experience in people management and talent retention. Key contributor to company culture and employee development, including training, mentorship, and team building.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.